Assessment of disease activity

Best Practice and Research: Clinical Rheumatology

Volumn 17, Issue 3, 2003, Pages 415-426

  Guillemin, Francis ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Arthritis; Chronic; Disease activity; Inflammatory; Measurement

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE;

ANKYLOSING SPONDYLITIS; ARTHROSCOPY; BIOLOGICAL MONITORING; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHRONIC INFLAMMATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MEASUREMENT; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PATIENT MONITORING; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RADIODIAGNOSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCLERODERMA; SELF REPORT; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ULTRASOUND; ARTICLE; CHRONIC DISEASE; REPRODUCIBILITY; ARTHRITIS; IMAGING; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS;

ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; SPONDYLITIS, ANKYLOSING;

EID: 0038038996     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(03)00026-3     Document Type: Review

References (61)

1. Fransen J, Uebelhart D, Stucki G et al. The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis. Annals of the Rheumatic Diseases 2002; 61: 225-231.
2. Wolfe F. The prognosis of rheumatoid arthritis: Assessment of disease activity and disease severity in the clinic. American Journal of Medicine 1997; 103: 12S-18S.
3. Symmons DP. Disease assessment indices: Activity, damage and severity. Baillière's Clinical Rheumatology 1995; 9: 267-285.
4. Fries JF, Hochberg MC, Medsger Jr. TA et al. Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis and Rheumatism 1994; 37: 454-462.
5. Bardwell WA, Nicassio PM, Weisman MH et al. Rheumatoid Arthritis Severity Scale: A brief, physician-completed scale not confounded by patient self-report of psychological functioning. Rheumatology (Oxford) 2002; 41: 38-45.
6. Van Riel PL & Schumacher Jr. HR. How does one assess early rheumatoid arthritis in daily clinical practice? Baillière's Clinical Rheumatology 2001; 15: 67-76.
7. Spoorenberg A, Van Der HD, De Klerk E et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. Journal of Rheumatology 1999; 26: 980-984.
8. Lloyd B, Campbell JP, Goldine CG et al. Standards for Educational and Psychological Testing. Washington: American Psychological Association, 1985.
9. Boers M, Brooks P, Strand CV & Tugwell P. The OMERACT filter for outcome measures in rheumatology. Journal of Rheumatology 1998; 25: 198-199.
10. Goldsmith CH, Smythe HA & Helewa A. Interpretation and power of a pooled index. Journal of Rheumatology 1993; 20: 575-578.
11. Van Der Heijde DM, Van't HM, Van Riel PL & Van De Putte LB. Validity of single variables and indices to measure disease activity in rheumatoid arthritis. Journal of Rheumatology 1993; 20: 538-541.
12. Kelley's Textbook of Rheumatology. Philadelphia: WB Saunders, 2000.
13. Van Leeuwen MA, Van Rijswijk MH, Sluiter WJ et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. Journal of Rheumatology 1997; 24: 20-27.
14. Sugimoto H, Takeda A & Kano S. Assessment of disease activity in rheumatoid arthritis using magnetic resonance imaging: Quantification of pannus volume in the hands. British Journal of Rheumatology 1998; 37: 854-861.
15. Lassere MN & Bird P. Measurements of rheumatoid arthritis disease activity and damage using magnetic resonance imaging. Truth and discrimination: Does MRI make the grade? Journal of Rheumatology 2001; 28: 1151-1157.
16. Carotti M, Salaffi F, Manganelli P et al. Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: A preliminary experience. Annals of the Rheumatic Diseases 2002; 61: 877-882.
17. Hau M, Schultz H, Tony HP et al. Evaluation of pannus and vascularization of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis by high-resolution ultrasound (multidimensional linear array). Arthritis and Rheumatism 1999; 42: 2303-2308.
18. Dwyer KA, Coty MB, Smith CA et al. A comparison of two methods of assessing disease activity in the joints. Nursing Research 2001; 50: 214-221.
19. Houssien DA, Stucki G & Scott DL. A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology (Oxford) 1999; 38: 48-52.
20. Van Gestel AM, Anderson JJ, Van Riel PL et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. Journal of Rheumatology 1999; 26: 705-711.
21. Van Der Heijde DM, Van't HM, Van Riel PL & Van De Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. Journal of Rheumatology 1993; 20: 579-581.
22. Prevoo MLL, Van't Hof MA & Van Riel PLCM. Modified disease activity scores that include twenty-eight joint counts. Arthritis and Rheumatism 1995; 38: 44-48.
23. Prevso MLL, Van Gestel AM, Van't Hof MA et al. Remission via propactive study of patients with rheumatoid arthritis. American rheumatism association preliminary remission criteria in relation to the disease activity score. British Journal of Rheumatology 1996; 35: 1101-1105.
24. Villaverde V, Balsa A, Cantalejo M et al. Activity indices in rheumatoid arthritis. Journal of Rheumatology 2000; 27: 2576-2581.
25. Smolen JS, Breedveld FC, Schiff MH et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 245-257.
26. Mason JH, Anderson JJ & Meenan RF. The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status. Arthritis and Rheumatism 1992; 35: 156-162.
27. Fransen J, Langenegger T, Michel BA & Stucki G. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 2000; 39: 321-327.
28. Paulus HE, Ramos B, Wong WK et al. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. Journal of Rheumatology 1999; 26: 2324-2331.
29. Lassere MN, Van Der Heijde D, Johnson KR et al. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: Implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials. Journal of Rheumatology 2001; 28: 892-903.
30. Salaffi F, Peroni M & Ferraccioli GF. Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: A comparison of the Chronic Arthritis Systemic Index, Disease Activity Score and Thompson's articular index. Rheumatology (Oxford) 2000; 39: 90-96.
31. Guillemin F, Suurmeijer T, Krol B et al. Functional disability in early rheumatoid arthritis: Description and risk factors. Journal of Rheumatology 1994; 21: 1051-1055.
32. Birrell FN, Hassell AB, Jones PW & Dawes PT. Why not use OSRA? A comparison of overall status in rheumatoid arthritis (RA) with ACR core set and other indices of disease activity in RA. Journal of Rheumatology 1998; 25: 1709-1715.
33. Barr SG, Zonana-Nacach A, Magder LS & Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis & Rheumatism 1999; 42: 2682-2688.
34. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis & Rheumatism 1992; 35: 630-640.
35. Gladman DD, Ibanez D & Urowitz MB. Systemic lupus erythematosus disease activity index 2000. Journal of Rheumatology 2002; 29: 288-291.
36. Bae SC, Koh HK, Chang DK et al. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 2001; 10: 405-409.
37. Corzillius M, Fortin P & Stucki G. Responsiveness and sensitivity to change of SLE disease activity measures. Lupus 1999; 8: 655-659.
38. Fortin PR, Abrahamowicz M, Clarke AE et al. Do lupus disease activity measures detect clinically important change? Journal of Rheumatology 2000; 27: 1421-1428.
39. Ward MM, Marx AS & Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. Journal of Rheumatology 2000; 27: 664-670.
40. Neville C, Clarke AE, Joseph L et al. Learning from discordance in patient and physician global assessments of systemic erythematosus disease activity. Journal of Rheumatology 2000; 27: 675-679.
41. Alarcon GS, McGwin Jr. G, Brooks K et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores. Arthritis & Rheumatism 2002; 47: 408-413.
42. Vitali C, Bencivelli W, Mosca M et al. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. Journal of Rheumatology 1999; 26: 498-501.
43. Liang MH, Socher SA, Larson MG & Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis & Rheumatism 1989; 32: 1107-1118.
44. Brunner HI, Feldman BM, Bombardier C & Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index. British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis & Rheumatism 1999; 42: 1354-1360.
45. Ruof J & Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: A literature review. Journal of Rheumatology 1999; 26:966-970.
46. Gaucher AA, Pere PG & Gillet PM. From ankylosing spondylitis to Foresteir's disease: Ossifying enthesopathy, a unifying concept. Journal of Rheumatology 1989; 16: 1020-1022.
47. Bakker C, Boers M & Van Der Linden S. Measures to assess ankylosing spondylitis: Taxonomy, review and recommendations. Journal of Rheumatology 1993; 20: 1724-1730.
48. Mander M, Simpson JM, McLellan A et al. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Annals of the Rheumatic Diseases 1987; 46: 197-202.
49. Creemers MC, 'T Hof MA, Franssen MJ et al. Disease activity in ankylosing spondylitis: Selection of a core set of variables and a first set in the development of a disease activity score. British Journal of Rheumatology 1996; 35z: 867-873.
50. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. Journal of Rheumatology 1994; 21: 2286-2291.
51. Calin A, Nakache JP, Gueguen A et al. Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 1999; 38: 878-882.
52. Eberl G, Studnicka-Benke A, Hitzelhammer H et al. Development of a disease activity index for the assessment of reactive arthritis (DAREA). Rheumatology (Oxford) 2000; 39: 148-155.
53. Asmussen K. Monitoring the disease activity. Scandinavian Journal of Rheumatology 2001; 115(supplement): 23-26.
54. Cantini F, Salvarani C, Olivieri I et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up study. Seminars in Arthritis and Rheumatism 2000; 30: 17-24.
55. Kyle V, Cawston TE & Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Annals of the Rheumatic Diseases 1989; 48: 667-671.
56. Merkel PA, Herlyn K, Martin RW et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis & Rheumatism 2002; 46: 2410-2420.
57. Della RA, Valentini G, Bombardieri S et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Annals of the Rheumatic Diseases 2001; 60: 585-591.
58. Symmons DP, Coppock JS, Bacon PA et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Quarterly Journal of Medicine 1988; 69: 927-937.
59. Petri M, Hellmann D & Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. Journal of Rheumatology 1992; 19: 53-59.
60. Urowitz MB, Gladman DD, Tozman EC & Goldsmith CH. The lupus activity criteria count (LACC). Journal of Rheumatology 1984; 11: 783-787.
61. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clinical Experimental Rheumatology 1992; 10: 541-547.